Zobrazeno 1 - 3
of 3
pro vyhledávání: ''
Autor:
Andrea Michelotti, Stefano Iacobelli, Giancarlo Bisagni, Patrizia Vici, Ilaria Ferrarini, Lucia Mentuccia, Corrado Ficorella, Isabella Sperduti, Stefania Gori, Riccardo Samaritani, Germano Zampa, Maria Mauri, Nicola Tinari, Michele Panebianco, Teresa Gamucci, Luca Moscetti, Clara Natoli, Laura Pizzuti, Michele De Tursi, Antonino Grassadonia
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Trastuzumab and chemotherapy is the current standard of care in HER2+ early or locally advanced breast cancer, but there are scanty literature data of its real world effectiveness. Methods We retrospectively reviewed 205 patients with HER2+ b
Autor:
L. Di Lauro, A. Vaccaro, M.A. Giampaolo, Lucia Mentuccia, Maria Agnese Fabbri, Luca Moscetti, F. Ciancola, Patrizia Vici, L. Pizzuti, Isabella Sperduti, Teresa Gamucci, Flavia Longo
Publikováno v:
Journal of Cancer Research and Clinical Oncology
Purpose Recurrences and deaths are known to occur, even if less frequently, in small, node-negative breast cancer patients, and decision on adjuvant treatments remains controversial. In the present analysis, we evaluate recurrence risk in patients wi
Autor:
Ahmet Bilici, A. Develi, Fugen Aker Vardar, B. B. Oven Ustaalioglu, Burcak Erkol, Ozlem Balvan, Mehmet Aliustaoglu
WOS: 000363023000009 PubMed ID: 26081286 In the literature, small number of study has addressed time of recurrence in breast cancer. We analyzed clinicopathological factors predicting early or late recurrence in breast cancer patients and also progno
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44efd2cf016e21514e701f35053f6f27
https://hdl.handle.net/20.500.12511/2220
https://hdl.handle.net/20.500.12511/2220